---
category: news
title: "Enzolytics Announces the Discovery and Patenting of Eleven Newly Identified Conserved Target Sites on the SARS-CoV-2 Virus (Coronavirus)"
excerpt: "Production of Monoclonal Antibodies Targeting These Sites Is in Process in the Company’s Texas Lab COLLEGE STATION, TX / ACCESSWIRE / February 22, 2021 / Enzolytics, Inc. (OTC Markets “ENZC” or the “Company”) today announced it has identified eleven conserved,"
publishedDateTime: 2021-02-22T15:45:00Z
originalUrl: "https://apnews.com/press-release/accesswire/science-business-technology-public-health-government-regulations-0b52f59f596faaf39676631741de8d24"
webUrl: "https://apnews.com/press-release/accesswire/science-business-technology-public-health-government-regulations-0b52f59f596faaf39676631741de8d24"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

secured: "unI89RF0skXbKARQAdQC5v4ACU2Nr0j1gjESv7pENE9dPY2u+ZLV88o2CVsS+PnIpphKSw6jwSWX/thg3prNu6ACFxwtajWI/khp/HIjE998CJ4Z0vb6fiqqsFbbtRkDVOdmUmjoWeT55Q7zDllbv+LZ8dQ9AsYrG2gvaBNNtRicKOKogN8spYPjvUS8cleZzCa85IarN00xgeDHV6BQFHXbOZCiCiQRAEFSiRN4n6k93nocMc9ZA0tB8NVNmpgYXfBCqY1W2ZsBjRWq7Frf/mAFF5/e/5iOU0Rcro72X0H8gJwmAtRHrWaayeuKAfJwyRbASF3F5GlA1gsvPBin4JmhJrW1kRicnpX49b7r508=;EN7OU+XFqlcctiZ2571OBg=="
---

